Perigon Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.12M | Buy |
|
|||||
|
2025
Q3 | $1.62M | Buy |
|
|||||
|
2025
Q2 | $1.43M | Buy |
|
|||||
|
2025
Q1 | $1.43M | Sell |
|
|||||
|
2024
Q4 | $1.31M | Buy |
|
|||||
|
2024
Q3 | $1.48M | Sell |
|
|||||
|
2024
Q2 | $1.49M | Buy |
|
|||||
|
2024
Q1 | $1.27M | Buy |
|
|||||
|
2023
Q4 | $1.2M | Sell |
|
|||||
|
2023
Q3 | $1.22M | Sell |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $451K | Buy |
|
|||||
|
2022
Q4 | $419K | Buy |
|
|||||
|
2022
Q3 | $302K | Sell |
|
|||||
|
2022
Q2 | $371K | Buy |
|
|||||
|
2022
Q1 | $292K | Buy |
|
|||||
|
2021
Q4 | $236K | Sell |
|
|||||
|
2021
Q3 | $256K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $46K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $33K | Sell |
|
|||||
|
2016
Q3 | $56K | Buy |
|